Share

Endocrine Society’s Insulin 2121 Event Kickstarts Diabetes Awareness Month

1796x943_Promo_The_Next_100_Years_of_Insulin_Title-Date (1) Throughout 2021, the Endocrine Society has focused on insulin’s past and present. The Society’s Insulin 2121 event highlights insulin’s future. Robots, drones, and artificial intelligence are just a few of the innovative topics being discussed. While the event is pre-recorded, our speakers will be live and available to answer your questions in real time during the Q&A portion.   More information on the...
Share

Safe, Non-Invasive Treatments Could Combat Obesity Epidemic

Novel obesity treatments such as modulation of the gut microbiome and gene therapy are underutilized and could help fight the obesity epidemic, according to a new manuscript published in Endocrine Reviews. Nearly half of the adults and 20% of children in the U.S. have obesity, yet doctors are under-prescribing effective weight loss medications and many patients are not receiving the treatment they need. The weight stigma that exists in healthcare settings makes...
Share

Society Leads Insulin Affordability Advocacy in 2021

This year marks the 100th anniversary of the discovery of insulin and despite this important milestone, the price of insulin remains too high for those who rely on it. In 2021, the Endocrine Society has been the leading voice in the diabetes community in urging Congress to address this ongoing crisis. While our work on...
Share

Making Educational Upgrades in a Digital World

Version 2 One of the priorities identified in the Society’s most recent Strategic Plan, SP4, was to focus on expanding our online programming. This could not have come at a more crucial time as the COVID-19 pandemic impacted our professional and personal lives, forcing us into a primarily digital lifestyle. As the Society shifted all in-person events...
Share

Handling Health Disparities One Patient at a Time

October 2021 Cover This month, Endocrine News takes a closer look at health disparities and some of the hurdles that clinicians face when treating these underserved populations. One of the biggest hurdles — whether in urban or rural areas — is the language barrier. When clinicians can’t adequately communicate with their patients, much-needed information can literally get lost...
Share

Found in Translation: New Diabetes Guides Increase Accessibility for All

anne Peters As high-tech innovations improve diabetes management, patients in underserved communities can often lag behind. Addressing the need for more education, Anne Peters, MD, spearheaded a new project that has created easy-to-read guides that make diabetes education easily understood by underserved populations. Type 1 diabetes is a challenging condition for any patient to manage, but it...
Share

Higher Fasting ‘Hunger Hormone’ Levels from Healthy Diet May Improve Heart Health and Metabolism

‘Green’ Mediterranean diet linked to elevated fasting ghrelin levels Fasting levels of the “hunger hormone” ghrelin rebound after weight loss and can help reduce belly fat and improve the body’s sensitivity to insulin, according to a study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Ghrelin is a stomach-derived hormone that stimulates...
Share

September 2021 Highlights: An Endocrinologist’s Inspiring Journey

EN_0921_cover The September issue’s cover story should be an inspiration for all of us. In “Never Too Late to Do Good,” senior editor Derek Bagley talks with Stanley Andrisse, PhD, MBA, who details his life story that saw him move from a prison cell in Missouri to researching fat cells as an assistant professor at Howard...